针对饮食障碍的普遍,选择性和指示性预防的干预措施的比较有效性和可接受性:系统审查和网络元分析的研究方案
Sandra Schlegl1, Felicitas Hirler2, Andreas Gerich2
1Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Nussbaumstrasse 7, 80336, Muenchen, Germany. sandra.schlegl@med.uni-muenchen.de.
Journal of eating disorders
|April 25, 2025
概括
本研究概述了一个网络元分析 (NMA) 协议,以比较饮食障碍 (ED) 预防策略的有效性. 它旨在确定不同人群和预防类型的最佳干预措施,以减少EDs的负担.
科学领域:
- 精神病学是一个精神病学.
- 公共卫生 公共卫生
- 证据综合 证据综合
背景情况:
- 饮食障碍 (ED) 是一种严重的精神疾病,具有高的慢性和死亡率.
- 有效的预防策略至关重要,初级预防分为通用,选择性和指示方法.
- 现有的审查存在局限性,缺乏风险组和干预类型之间的比较有效性.
研究的目的:
- 概述一个系统审查和网络元分析 (NMA) 协议.
- 评估各种ED预防干预措施的比较有效性.
- 评估跨不同预防类型和人群的干预措施.
主要方法:
- 对 (集群) 随机对照试验 (RCT) 的系统审查和频率网络元分析 (NMA).
- 包括在不同环境中对儿童,青少年和成年人的研究.
- 评估针对ED,饮食失调,负面身体形象或风险因素的心理,教育,身体和营养干预措施.
主要成果:
- 首要结局包括ED诊断症状,整体ED病理,ED发病,以及干预的可接受性 (因任何原因停止治疗).
- 将进行灵敏度和子组分析以确定效果修饰剂.
- 这代表了第一个NMA专注于ED预防的比较有效性.
结论:
- 国家药物管理局将确定最有效的ED预防干预措施.
- 结果将为临床实践,研究重点和公共卫生政策提供信息.
- 该研究旨在通过基于证据的预防来减少饮食障碍的社会负担.
相关概念视频
Anorexia Nervosa
33
Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
33
Binge Eating Disorders
35
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
35
Bulimia Nervosa
33
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
33
Comparing the Survival Analysis of Two or More Groups
85
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
85
Nursing Interventions II: Selecting and Classifying the Nursing Interventions
2.0K
Creating and executing a nursing diagnosis helps nurses plan care and guide patient, family, and community interventions. They are developed based on a patient's physical evaluation and support measuring the outcomes. It is not recommended to select random interventions throughout the planning process. Instead, consider the following six essential factors when choosing interventions:
2.0K
Hazard Ratio
67
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
67


